RESULTS OF AN OPEN-LABEL, DOSE-RANGING, SAFETY AND PHARMACOKINETIC TRIAL OF THE HUMANIZED TUMOR-NECROSIS-FACTOR ANTIBODY (HTA), BAY-103356,IN PATIENTS WITH ACTIVE RHEUMATOID-ARTHRITIS (RA)

Authors
EVANS J YOCUM DE MARICIC M GLUCK O TESSER J CHEN Z BAYLINK DJ FLETCHER MP
Citation
J. Evans et al., RESULTS OF AN OPEN-LABEL, DOSE-RANGING, SAFETY AND PHARMACOKINETIC TRIAL OF THE HUMANIZED TUMOR-NECROSIS-FACTOR ANTIBODY (HTA), BAY-103356,IN PATIENTS WITH ACTIVE RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 40(9), 1997, pp. 1158-1158
Citations number
NO
Categorie Soggetti
Rheumatology
Journal title
Arthritis and rheumatism → ACNP
ISSN journal
00043591
Volume
40
Issue
9
Year of publication
1997
Supplement
S
Pages
1158 - 1158
Database
ISI
SICI code
0004-3591(1997)40:9<1158:ROAODS>2.0.ZU;2-H